Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
University of Colorado, Denver · with Colorado Clinical & Translational Sciences Institute · NCT06686537
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–38 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 2
- Target enrollment
- 20
- US sites recruiting
- 2
- Study start
- February 25, 2025
- Record last updated
- July 21, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Dr. Nanette Santoro proposes to test the specific question that obesity results in abnormal estradiol response at the level of the pituitary and hypothalamus. This will be shown in diminished pituitary sensitivity to gonadorelin releasing hormone with a reduced estradiol induced luteinizing hormone surge in obese women.
Being studied: Estradiol Patches
Conditions: Infertility, Female; Obesity
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 18-38
- Regular menstrual cycles every 25-35 days
- No use of reproductive hormones within the past 3 months
- No use of medications interacting with reproductive hormones
- Agreement to use reliable barrier contraception or to abstain from intercourse for the duration of the study
- Normal thyroid stimulating hormone, prolactin and lipid profiles
- No more than 4 hours of moderate to vigorous intensity exercise per week
- No history of chronic disease impacting reproductive hormones
- No contraindications to administration of estradiol
- No history of estrogen dependent cancer
- Negative pregnancy test
Exclusion Criteria
- Has diabetes
- Is a smoker
- History of venous thromboembolism or known thrombophilia
Recruiting US locations
University of Colorado School of Medicine
Aurora, CO 80045
University of Colorado-School of Medicine
Aurora, CO 80045
Site contact: Asma Giornazi, MS · 303-724-5276 · Asma.Giornazi@cuanschutz.edu
Study contacts (from the official record)
- Carrie Hsu · 303-724-5276 · Carire.Hsu@cuanschutz.edu
- Asma Giornazi · asma.giornazi@cuanschutz.edu
Similar studies in Colorado
All weight loss studies in Colorado →- RecruitingHealthy volunteersPhase 1
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
University of Colorado, Denver
- Location
- Aurora, CO
- Eligibility basics
- Ages 19–37 · Women only
- RecruitingPhase 3
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
AstraZeneca
- Location
- Arvada, CO + 43 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Eli Lilly and Company
- Location
- Lakewood, CO + 17 other US sites
- Eligibility basics
- Ages 18+ · Women only
- RecruitingPhase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Eli Lilly and Company
- Location
- Aurora, CO + 59 other US sites
- Eligibility basics
- Ages 18+